Akoya Biosciences Inc

+0.28 (+4.91%)
4:56:10 PM EDT: $5.98 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)229.66M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$22.5 Million
Adjusted EPS-$0.46
See more estimates
10-Day MA$5.86
50-Day MA$6.86
200-Day MA$10.50
See more pivots

Akoya Biosciences Inc Stock, NASDAQ:AKYA

100 Campus Drive, 6th Floor, Marlborough, Massachusetts 01752
United States of America
Phone: +1.855.896.8401
Number of Employees: 369


Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.